Sequoia Capital leads $50m Series C in Chinese biotech startup Adagene

Sequoia Capital leads $50m Series C in Chinese biotech startup Adagene

Photo: Pixabay

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter